Henri Mondor University Hospital

aphp.fr

Total trials

25

Active

0

Phase 3

1

Total enrollment

14,273

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Parkinson Disease3
  • Walking, Difficulty3
  • Diagnoses Disease2
  • Neurologic Disorder2
  • Stroke2
  • Immune Thrombocytopenia2
  • Parkinson1
  • Cerebellar Tumor1

Frequently asked questions about Henri Mondor University Hospital

How many clinical trials does Henri Mondor University Hospital have on ClinicalTrials.gov?
Henri Mondor University Hospital is listed as the lead sponsor on 25 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
How many of Henri Mondor University Hospital's trials are in Phase 3?
1 of Henri Mondor University Hospital's trials are in Phase 3.
What therapeutic areas does Henri Mondor University Hospital focus on?
Henri Mondor University Hospital's most-studied conditions on ClinicalTrials.gov are Parkinson Disease, Walking, Difficulty, Diagnoses Disease, Neurologic Disorder, Stroke.